{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:00:33Z","timestamp":1792116033878,"version":"4.4.0"},"reference-count":66,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World j. surg."],"published-print":{"date-parts":[[1993,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Gut tumor syndromes are rare, occurring in less than two cases per million population per year: Insulinomas are most common and gastrinomas are less common; all the others are extremely rare. Conventional treatment of the symptoms caused by these tumors has included surgery, hepatic arterial embolization, and chemotherapy; some patients with Zollinger\u2010Ellison syndrome (ZES) have been treated with specific agents such as gastric antisecretory drugs. The development of octreotide, a synthetic, long\u2010acting analogue of the natural peptide somatostatin, has offered an alternative to such therapies. Octreotide has a half life of &gt;100\u00a0minutes and inhibits both physiological\u2010 and tumor release of many peptides. It also has direct effects on the gut that modify secretion and motility. Octreotide has been shown to be particularly useful for the symptoms of tumors producing vasoactive intestinal peptide (VIP), and of the carcinoid syndrome. It is also useful in patients with glucagonomas, with growth hormone\u2010releasing hormone producing tumors, and in some patients with Cushing's syndrome and unresectable insulinomas. Octreotide is effective in patients with ZES, but alternative therapies such as omeprazole are more effective, safer, and more convenient for those patients. Side effects of octreotide have not been troublesome in these patients, but the incidence of long term effects is still not entirely clear. Octreotide has proved to be a significant advance in the treatment of patients with islet cell tumors<\/jats:bold>.<\/jats:p>","DOI":"10.1007\/bf01655110","type":"journal-article","created":{"date-parts":[[2005,5,8]],"date-time":"2005-05-08T03:39:28Z","timestamp":1115523568000},"page":"504-510","source":"Crossref","is-referenced-by-count":44,"title":["Use of octreotide acetate for control of symptoms in patients with islet cell tumors"],"prefix":"10.1002","volume":"17","author":[{"given":"Paul N.","family":"Maton","sequence":"first","affiliation":[{"name":"Oklahoma Foundation for Digestive Research 711 Stanton L. Young Boulevard, Suite 501 73104 Oklahoma City OK USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1993,7]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"763","volume-title":"The Exocrine Pancreas: Biology, Pathobiology and Diseases","author":"Ch'ng J.L.C.","year":"1986"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198203113061005"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607033150101"},{"key":"e_1_2_1_5_1","first-page":"727","volume-title":"the Exocrine Pancreas: Biology, Pathobiology, and Diseases","author":"Jensen R.T.","year":"1986"},{"key":"e_1_2_1_6_1","first-page":"745","volume-title":"The Exocrine Pancreas: Biology, Pathobiology, and Diseases","author":"Comi R.J.","year":"1986"},{"key":"e_1_2_1_7_1","first-page":"620","volume-title":"Textbook of Gastroenterology","author":"Maton P.N.","year":"1985"},{"issue":"6","key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(86)90581-4","article-title":"Neuroendocrine tumors: a European view","volume":"81","author":"Buchanan K.D.","year":"1979","journal-title":"Am. J. Med."},{"key":"e_1_2_1_9_1","first-page":"191","volume-title":"International Radiology","author":"Allison D.J.","year":"1982"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6397.932"},{"key":"e_1_2_1_11_1","first-page":"847","article-title":"Recent advances in the management of gastric acid hypersecretion in patients with Zollinger\u2010Ellison syndrome. Gastroenterol","volume":"18","author":"Maton P.N.","year":"1989","journal-title":"Clin. North Am."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1166308"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.184.4135.482"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)90869-1"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90182-9"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312153092406"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197811092991908"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.22.7.549"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)92115-9"},{"key":"e_1_2_1_20_1","first-page":"821","article-title":"Investigation and treatment of a recurrent vipoma","volume":"16","author":"Lennon J.R.","year":"1975","journal-title":"Gut"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01295657"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-4-675"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197506262922606"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92640-9"},{"key":"e_1_2_1_25_1","unstructured":"Berchtold P. Berger M. Wiegelmann W. et al.:Serum insulin suppression by somatostatin diazoxide and phenytoin in insulinoma patients [abstract 229]. Fifth International Congress of Endocrinology Hamburg 1976."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.32.10.921"},{"key":"e_1_2_1_27_1","first-page":"525","article-title":"Effect of somatostatin on basal and glucose induced insulin release in five patients with hyperinsulinaemia","volume":"81","author":"Efendic S.","year":"1976","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.3.190"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03348310"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90572-3"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-3-543"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1985.tb08855.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-48-1-50"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90087-X"},{"key":"e_1_2_1_35_1","first-page":"433","article-title":"Endocrine profile of a long\u2010acting somatostatin derivative SMS 201\u2010995: study in normal volunteers following subcutaneous administration","volume":"111","author":"Del Pozo E.","year":"1986","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02012573"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000199408"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000199820"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.1.248"},{"key":"e_1_2_1_40_1","first-page":"108","article-title":"Somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth","volume":"109","author":"Reubi J.C.","year":"1984","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01655111"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-1-35"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(21)00447-7"},{"key":"e_1_2_1_44_1","first-page":"311","article-title":"Traitement de la maladie de Cushing par un analogue de la somatostatine (SMS 201\u2010995): quatres observations","volume":"50","author":"Lorcy Y.","year":"1988","journal-title":"Ann. Endocrinol (Paris)"},{"issue":"1","key":"e_1_2_1_45_1","first-page":"201","article-title":"Effect of a long\u2010acting somatostatin analogue, SMS 201\u2010995, on ACTH secretion in normal subjects and in patients with Cushing's syndrome [abstract]","volume":"12","author":"Invitti C.","year":"1989","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"e_1_2_1_46_1","first-page":"147","article-title":"Acute administration of somatostatin or its analog SMS 201\u2010995 does not influence plasma ACTH levels in patients with corticotrophin hypersecretion [abstract]","volume":"12","author":"Ambrosi B.","year":"1989","journal-title":"J. Endocrinol. Invest."},{"key":"e_1_2_1_47_1","first-page":"760","article-title":"The effect of the long\u2010acting somatostatin analogue SMS 201\u2010995 on ACTH secretion in Nelson's syndrome and Cushing's disease","volume":"720","author":"Lamberts S.W.J.","year":"1989","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01468882"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-162"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-198812000-00014"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-9-4-417"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197908093010601"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-5-917"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-5-1254"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6699.604"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90139-X"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-70-4-1193"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004850"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-3-173"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-6-1658"},{"key":"e_1_2_1_61_1","first-page":"A580","article-title":"Gallstone formation and occurrence of cholesterol monohydrate crystals in gallbladder bile of patients with long\u2010term Sandostatin treatment","volume":"96","author":"Buscail L.","year":"1989","journal-title":"Gastroenterology"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-3-557"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-3-159"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-2-391"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-6-1127"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91258-0"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(88)90221-2"}],"container-title":["World Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01655110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01655110\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/BF01655110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T18:44:19Z","timestamp":1704998659000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/BF01655110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["10.1007\/BF01655110"],"URL":"https:\/\/doi.org\/10.1007\/bf01655110","archive":["Portico"],"relation":{},"ISSN":["0364-2313","1432-2323"],"issn-type":[{"value":"0364-2313","type":"print"},{"value":"1432-2323","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}